Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 15:135:177-180.
doi: 10.1016/j.amjcard.2020.08.033. Epub 2020 Aug 29.

Ventricular Fibrillation Storm in Coronavirus 2019

Ossama Elsaid  1 , Peter A McCullough  2 , Kristen M Tecson  3 , Ryan S Williams  4 , Anthony Yoon  4
Affiliations
Review

Ventricular Fibrillation Storm in Coronavirus 2019

Ossama Elsaid et al. Am J Cardiol. .

Abstract

Cardiac arrhythmia is a known manifestation of novel coronavirus 2019 (COVID-19) infection. Herein, we describe the clinical course of an otherwise healthy patient who experienced persistent ventricular tachycardia and fibrillation which is believed to be directly related to inflammation, as opposed to acute myocardial injury or medications that can prolong the QT interval.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Electrocardiogram of the patient with ventricular fibrillation.
Figure 2
Figure 2
A Venn diagram illustrating the hypothesis that this patient's ventricular tachycardia resulted from a scenario involving a multitude of factors (abnormal labs, renal injury, long QTC, and inflammation). In order for the ventricular tachycardia to occur, these factors need to happen together. Conversely, a normal patient who happens to have a high degree of inflammation will not have ventricular tachycardia if other variables in the Venn diagram are absent. TdP = Torsades de Pointe.
See this image and copyright information in PMC

References

    1. World Health Organization. Coronavirus Disease (COVID-19) Situation Reports. Available at:https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed on June 5, 2020.
    1. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular Considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. 2020;75:2352–2371. - PMC - PubMed
    1. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1–8. - PMC - PubMed
    1. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Jr, Nahid M, Ringel JB, Hoffman KL, Alshak MN, Li HA, Wehmeyer GT, Rajan M, Reshetnyak E, Hupert N, Horn EM, Martinez FJ, Gulick RM, Safford MM. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382:2372–2374. - PMC - PubMed
    1. Kochav SM, Coromilas E, Nalbandian A, Ranard LS, Gupta A, Chung MK, Gopinathannair R, Biviano AB, Garan H, Wan EY. Cardiac arrhythmias in COVID-19 infection. Circ Arrhythm Electrophysiol. 2020;13 - PMC - PubMed

MeSH terms

Substances